Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,889 | -116,045 | -133,816 | -121,755 | -78,996 |
| Depreciation Amortization | 5,089 | 1,198 | -485 | 4,144 | 5,450 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 345 |
| Accounts receivable | -236 | 1,968 | 11,704 | 3,258 | -84 |
| Accounts payable and accrued liabilities | -1,311 | -414 | -1,151 | -4,634 | 3,774 |
| Other Working Capital | 39,909 | 7,130 | 8,024 | 6,789 | -13,688 |
| Other Operating Activity | 19,166 | 27,399 | 12,570 | 27,416 | 13,203 |
| Operating Cash Flow | $-19,272 | $-78,764 | $-103,154 | $-84,782 | $-69,996 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,896 | -17,948 | -9,058 | -2,125 | -750 |
| Purchase Of Investment | -209,629 | -307,282 | -373,391 | -171,446 | -307,348 |
| Sale Of Investment | 262,872 | 383,465 | 328,871 | 228,468 | 345,089 |
| Investing Cash Flow | $40,347 | $58,235 | $-53,578 | $54,897 | $36,991 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 145 | 147 | 2,208 | 21,262 | 3,614 |
| Other Financing Activity | -26,763 | -27,773 | 195,918 | -1,229 | -534 |
| Financing Cash Flow | $-26,618 | $-27,626 | $198,126 | $20,033 | $3,080 |
| Beginning Cash Position | 41,201 | 89,356 | 47,962 | 57,814 | 87,739 |
| End Cash Position | 35,658 | 41,201 | 89,356 | 47,962 | 57,814 |
| Net Cash Flow | $-5,543 | $-48,155 | $41,394 | $-9,852 | $-29,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,272 | -78,764 | -103,154 | -84,782 | -69,996 |
| Capital Expenditure | -12,896 | -17,948 | -9,058 | -2,125 | -750 |
| Free Cash Flow | -32,168 | -96,712 | -112,212 | -86,907 | -70,746 |